Email steve@steveariens.com 502-938-2414
Pay Attention
This is a graphic representing the fictitious clinical facts that are starting to hit the fan Does the DEA have any statutory authority to establish medical standard of care and best practices under the controlled substance act? The Drug Enforcement Administration (DEA) does not have statutory authority to establish medical standards of care and best […]
Filed under: General Problems | 1 Comment »
This is a graphic representing the fictitious clinical facts that are starting to hit the fan Is there any clinical justification to establish fixed opioid doses to treat chronic pain less than the FDA dosing guidelines Based on the available information, there is generally no clinical justification to establish […]
Filed under: General Problems | Leave a Comment »
Here is a published MME calculator https://globalrph.com/medcalcs/morphine-equivalent-dose-med-opioid-conversions/ This is the infamous MME system that those “so-called experts” based their 2016 CDC opioid dosing guidelines and what many bureaucracies – like the DEA & VA – seemed to have codified those guidelines as a standard of care and best practices as well as maybe 30+ states […]
Filed under: General Problems | Leave a Comment »
Here is a published BME calculator https://globalrph.com/medcalcs/benzodiazepine-converter-dosage-conversions/ Narxcare creates what they call an LME (Lorazepam Milligram Equivalent) value and includes it in their Narxcare PDM reports on pts that authorized healthcare professional can pull up reports on pts. This is a graphic representing the fictitious clinical facts that are […]
Filed under: General Problems | Leave a Comment »
How will the end of Chevron deference impact the DEA rules and regulations and enforcement of existing interpretations of the Control Substance Act that the DEA has made since its inception in 1973, which are now probably illegal? The Supreme Court’s decision to overturn Chevron’s deference will likely have significant implications for the Drug Enforcement […]
Filed under: General Problems | 2 Comments »
CMS Incentivizes Payor Health Disparity Performance https://www.specialtypharmacycontinuum.com/Policy/Article/06-24/CMS-Incentivizes-Payor-Health-Disparity-Performance/74138 Medicare Advantage and other health plans are starting to pay more attention to medication adherence, social determinants or drivers of health (SDOH), and where they can intervene in health disparities—not only because it’s the right thing to do but because it will soon affect their bottom line, speakers […]
Filed under: General Problems | Leave a Comment »
Supreme Court guts agency power in seismic Chevron ruling https://www.axios.com/2024/06/28/supreme-court-chevron-doctrine-ruling The Supreme Court on Friday curtailed the executive branch’s ability to interpret laws it’s charged with implementing, giving the judiciary more say in what federal agencies can do. Why it matters: The landmark 6-3 ruling along ideological lines overturns the court’s 40-year-old “Chevron deference” doctrine. […]
Filed under: General Problems | 1 Comment »
I made this blog post a couple of days ago and today got around to watching the video that I shared in the blog post. The 10 minute video is made by a non-profit that seems opposed to these guidelines. UPDATED:Proposed tapering guideline by American Society of Addiction Medicine some well-thought-out suggestions in commenting, like […]
Filed under: General Problems | 5 Comments »
https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/bzd-cpg-narrative-draft-for-public-comment.pdf?sfvrsn=6d96408_1 Above is the link that shows in the graphic – may have to click on the graphic a couple of times to get it to resize properly Link to make comment https://bit.ly/BZDCPG I went back and did a few word searches. I really didn’t feel like reading 146 pages. The words I searched for […]
Filed under: General Problems | 6 Comments »
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness https://www.cnn.com/2024/07/03/health/ozempic-wegovy-blindness-rare-risk/index.html People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say it shouldn’t deter patients from using the medicines to treat diabetes or obesity. Last […]
Filed under: General Problems | Leave a Comment »
